A s bstract. Well-myelinated cultures of mouse dorsal root ganglia incubated for 48 h with 6-aminolevulinic acid (ALA) showed intense porphyrin fluorescence localized in myelin sheaths but not in axons or neuronal somata. When the cultures were continuously incubated with a high concentration of lead, focal swelling and segmental degeneration of myelin began to develop within 2 wk. Incubation of cultures with ALA after 3 wk of lead treatment revealed markedly decreased porphyrin fluorescence in myelin sheaths compared with untreated controls. After 6 wk of lead treatment, myelin showed severe segmental degeneration. Porphyrin fluorescence from ALA at this time was barely detectable in these cultures. No fluorescence was visible in the demyelinated axons; however, silver-impregnation staining after fixation demonstrated continuity of the axon despite the severe loss of myelin. When cultures were continuously incubated with lead and heme together for 6 wk, the segmental demyelination seen in cultures treated with lead alone did not occur. These findings suggest that the lead-induced segmental demyelination in cultured mouse dorsal root ganglia may be due to toxic effects of the metal on the heme biosynthetic pathway in myelinating cells and that exogenous heme may counteract this toxic effect of lead.
Introduction
Segmental demyelination of peripheral nerves in experimental animals as a consequence of chronic lead toxicity was first deReceived for publication 5 May 1983 and in revised form 26 March 1984. scribed by Gombault in 1880 (1) . Subsequent studies have shown variability in this change in myelin during chronic lead exposure. This variability has been attributed in part to age and species differences in animals and to differences in duration ofexposure and doses of lead employed in such studies (2) (3) (4) (5) (6) . Although there is no conclusive evidence as to whether lead primarily affects neuronal elements, non-neuronal elements, or both, studies dealing with this question (3) (4) (5) have suggested that lead produces a primary lesion in Schwann cells and that the neuronal lesions are due, in part, to pathological changes that occur in these supporting cells.
Studies in non-nervous tissues such as hematopoietic cells and liver (7) (8) (9) (10) (11) (12) have identified toxic effects of lead on specific enzymes of the heme biosynthetic pathway. Recent studies that used organotypic cultures of dorsal root ganglia derived from the chick (13, 14) and the mouse (15) have provided clear evidence for the presence of the porphyrin-heme biosynthetic pathway in this peripheral nervous system tissue. Porphyrin synthetic activity in this tissue system was shown to be localized predominantly in Schwann cells rather than in neuronal cells and was sensitive to the toxic effects of lead (14) .
The fact that chronic lead exposure produces damage to Schwann cells (3) (4) (5) , the demonstration that lead impairs the integrity of the heme biosynthetic pathway (7) (8) (9) (10) (11) (12) , and the primary localization of the pathway in the supporting elements of dorsal root ganglia (13) (14) (15) have led us to study the possible relationship between lead-induced demyelination and impaired porphyrin-heme biosynthesis in this model system.
Methods Preparation and treatment of the cuftures
Cultures of mouse dorsal root ganglia were selected for this study because of their capacity to produce abundant myelin under normal culture conditions. Cultures were prepared from 16-18-d fetuses. Ganglia were removed under sterile conditions via the dorsal approach. For each culture, two ganglia were placed directly on a collagen-coated glass coverslip carrying 50 ,ul of nutritive medium composed of Eagle's minimal essential medium (60%), 9-d chick embryo extract (10%), human placental serum (30%), glucose (6 mg/ml), and nerve growth factor (Collaborative Research, Inc., Waltham, MA) (250 U/ml). The coverslips were then sealed individually into a Maximow chamber (double-coverslip assembly). Subsequently, the cultures received fresh medium twice a week, but no further washing was carried out.
Cultures were examined with bright-field optics and sequentially photographed in the resting state or under experimental conditions. Fixation for light-microscopic staining procedures was carried out by immersing the coverslip directly in the fixative. The Treatment with heme. Four well-myelinated cultures were incubated with heme in the medium in a final concentration of 100 MM for up to 6 wk. As in the lead-exposed cultures, heme was replenished twice a week at the regular intervals. These cultures were sequentially photographed by bright-field optics.
Treatment with heme-plus-lead. 16 well-myelinated cultures were continuously incubated with heme, 0.1-100 MM, and lead acetate, 10 MM, for periods of up to 6 wk. These cultures were sequentially photographed through bright-field optics. Five of the cultures were incubated in 10 mM ALA (after 6 wk lead-plus-heme exposure) and studied by fluorescence microscopy as described above.
Staining procedures. After continuous treatment with lead, heme, or heme-plus-lead for 6 :
Sequential light-microscopic observations in the experimental cultures showed that by 10-14 d of lead treatment, individual myelinated nerve fibers showed a consistent though minimal retraction of the ends of adjacent segments of myelin at the nodes of Ranvier. As this early change developed, the nodes of Ranvier became more prominent, the myelin at these points appeared somewhat swollen or bulbous, and axons beneath the retracting myelin became increasingly exposed or bared (Fig. 1) . Subsequently focal, then elongated, dilatations occurred along the length of the myelin sheaths. As the loss of myelin progressed, Schwann cell nuclei retained their positions along the axons. At the end of the 6-wk treatment period, the leadtreated cultures showed long gaps in the myelin sheaths, each gap representing an exaggeration ofthe original node of Ranvier ( Fig. 1) .
At 3 and 6 wk of lead treatment, cultures were also incubated with ALA (10 mM) for 48 h and studied and photographed by darkfield and fluorescence microscopy. Compared with control cultures (Fig. 2 A) , at 3 wk oflead treatment (Fig. 2 B) porphyrin fluorescence was variable and showed patchy red intensity along the otherwise weakly fluorescent myelin sheath. Neither in control cultures nor in lead-treated cultures was fluorescence observed in the bare axonal regions of the nodes of Ranvier. Porphyrin fluorescence in cultures treated with lead for 6 wk was barely detectable (Fig. 2 C) and could be seen only in the remnants of the myelin sheath along the axons and not in the demyelinated axons themselves.
When the lead-treated cultures were stained for myelin, degeneration of myelin was evidenced by a marked reduction in internodal lengths ofthe myelin segments, with prominent blebbing and deformation of the remaining segments. The cultures incubated with heme alone for 5 wk showed no visible changes in myelin configuration or in morphology of other structures. At the concentration of heme used (Figs. [2] [3] [4] , there were no detectable morphological effects on the cultures.
Sequential observations ofcultures simultaneously incubated in lead-plus-heme showed that with the lower heme concentrations (0.1-10 ,uM), myelin degeneration indistinguishable from that observed in cultures treated with lead alone was produced. In cultures incubated with the highest dosage of heme (100 gM) and with lead, the changes produced in myelin were limited to the appearance of scattered small focal dilatations of the myelin sheaths; no progressive widening of the nodes of Ranvier or disappearance of myelin could be detected in the living cultures (Fig. 3) or in cultures fixed after 6 wk of exposure and stained with Sudan black B (Figs. 2 D and 4 C) . These findings were confirmed by morphometry (Table I ). The latter cultures, however, when incubated with ALA for 48 h, exhibited diminution of porphyrin fluorescence (Fig. 2 D) similar to that observed in cultures exposed to lead alone. Control cultures incubated with heme alone (100 jiM) for 6 wk showed no changes in the appearance of myelinated fibers. Silver-impregnation staining oflead-treated cultures showed that despite the presence of severe retraction and loss of myelin, the axis cylinders could still be shown to retain their original courses and configurations over the collagen surface (Fig. 5) . A striking incidental observation with silver-stain preparations was the abundance of small unmyelinated nerve fibers still present after the 6-wk lead treatment period.
Discussion
The results of the present study support the idea that there is a relationship between lead-induced impairment ofporphyrinogenesis in cultured dorsal root ganglia cells and the demyelinating process produced as a consequence of sustained exposure of such cells to this metal. In this study control cultures of mouse dorsal root ganglia incubated with ALA for 48 h developed a prominent porphyrin fluorescence which was observed almost exclusively in myelin sheaths; no fluorescence was detected in the nerve fibers themselves, whether or not they were myelinated.
When cultures were continuously exposed to lead under the conditions described and then incubated with ALA for 48 h, the intensity of the porphyrin fluorescence in myelin sheaths was progressively diminished as the treatment time increased. Simultaneously, the myelin sheaths underwent segmental degeneration characterized first by focal swelling and then shrinkage away from the nodes of Ranvier so that the nodes became increasingly wide. Continuity of demyelinated axons could, however, be demonstrated by silver impregnation staining even after severe loss of myelin had occurred. In cultures continuously treated with lead and a high concentration of heme for 6 wk, myelin was spared the severe degenerative changes observed in the cultures exposed to lead alone. Porphyrin fluorescence in these lead-plus-heme treated cultures was diminished to an extent equivalent to that seen in lead-treated cultures; however, the myelin sheaths in the lead-plus-heme cultures were well preserved, in contrast to cultures exposed to lead alone. Morpho- metric analysis of nerve fibers corroborated the protective effect of heme against lead-induced demyelination (Table I) . The earliest systematic description of pathological findings in experimental lead neuropathy is that of Gombault (1), who observed that during chronic lead exposure, guinea pigs developed a peripheral neuropathy characterized by segmental demyelination but without apparent damage to axons. Subsequent studies have reported both segmental demyelination and Wallerian degeneration, which occur to a variable degree depending on the species and the age of animals and on the dosage and duration of lead treatment (2) (3) (4) (5) (6) (4) 2.6±1.1 Mm (6) 3.4±2.4 Am (3) 4.9±1.5 Mm (5) 5.3±0.6 Mm (5) Lead-plus-heme treatment (4) 2.1±0.5 Mrm (4) Cultures were treated with lead (10 MM) alone or lead-plus-heme (100 MM) for up to 6 wk, and the widths of the nodes of Ranvier (n = [3] [4] [5] [6] were determined in the cultures and expressed as the mean±SD. Numbers of nodes measured are indicated in parentheses. No changes in the nodes of Ranvier were noted in cultures incubated in heme alone for 6 wk.
there are indications that damage to Schwann cells by lead may represent the primary lesion responsible for demyelination as well as for axonal degeneration. Schlaepfer (3) has suggested that the combination of sensory neuronal degeneration and segmental demyelination observed in rats exposed to lead for periods of 3 to 18 mo could be explained by a metabolic lesion in Schwann cells, including satellite cells. Biochemical mechanisms involved in lead toxicity in the nervous system have not been fully elucidated. Lead neuropathy may result from the effects of the metal on different elements of the nervous system including vessels, Schwann cells, stromal cells, and nerve cells (6) . Several hypotheses concerning possible biochemical mechanisms for lead toxicity in the central nervous system in experimental models have been proposed (17) (18) (19) . However, there has been less focus on the possible mechanism ofthe demyelination produced by lead in the peripheral nervous system (2) (3) (4) (5) (6) 20) . Studies dealing with this aspect oflead toxicity have suggested either that a lead-induced disturbance ofcalcium transport may cause swelling and damage to Schwann cells (20) or that the metal may inhibit the porphyrin-heme biosynthetic pathway in non-neuronal supporting elements, specifically those cells responsible for myelin formation (13) (14) (15) .
The studies of Kliiver (21, 22) and more recently of Asbury (23) have indicated the presence of a porphyrin biosynthetic pathway in the nervous system (13) (14) (15) . The possible relationship between the toxic effects of lead on this pathway and on the myelination of nerve fibers in culture have not been previously examined. A major difficulty in conducting such studies had been the unavailability of living, undisturbed, morphologically intact, and biochemically active nervous tissues. The availability oftechniques for culturing nervous system tissue organotypically (24, 25) so that the various components retain their morphologic as well as biochemical cell-to-cell relationships in vitro now permits examination ofthe activity ofthe porphyrin-heme pathway and the effect on this pathway of the prototype environmental toxin, lead. Previous studies in cultures of avian and mammalian peripheral nervous system tissues have demonstrated an intrinsic porphyrin-heme biosynthetic pathway in such tissues and suggested that the pathway is principally localized to non-neuronal elements, specifically Schwann cells and other supporting cells (13) (14) (15) . These cells, elements of which are critically involved in myelin formation, have been shown to be able to synthesize at least six porphyrin intermediates of the heme biosynthetic pathway when incubated with a precursor, ALA (14) .
The myelin degeneration and concomitant diminution of induced porphyrin fluorescence observed in the ganglion cultures during chronic lead exposure indicate that this metal may produce local inhibition of the porphyrin-heme biosynthetic sequence. As a consequence ofthis inhibition, porphyrin formation from the precursor, ALA, is reduced, and the conversion of porphyrins to heme is probably also inhibited. Evidence on this point is circumstantial in studies that use nerve cell cultures but is consistent with the effects of lead on ferrochelatase activity in other tissues treated with the metal (5, 14) . If heme is essential to the metabolic capacity of Schwann cells to maintain or form myelin, then deprivation of heme through such an inhibitory mechanism could be involved in the degenerative changes that occur in the peripheral nervous system in lead toxicity. Segmental demyelination may represent an early visible sign of Schwann cell damage as a consequence of lead inhibition of heme synthesis. This idea is consistent with the observation in this study that exogenously supplied heme was able to exert a protective effect against lead-induced myelin degeneration in the cultured nerve cells. The mechanism of this protective effect of heme on myelin preservation is not known. It is conceivable that when cellular heme synthesis is inhibited by lead, an exogenous supply of heme may circumvent the lead effect, thus preserving the functional integrity ofSchwann cells that sustain the myelin sheath. It is of interest in this regard that exogenous heme may reverse some of the abnormalities in patients with lead poisoning (26).
It should be emphasized that a high concentration of exogenous heme was required to counteract the toxic effect of lead on nerve myelin formation in this study. High concentrations (50-100 ,uM) of heme are also required for stimulation ofprotein synthesis in in vitro cell-free systems (27) ; stimulation of neuronal differentiation of mouse neuroblastoma cells (28) ; erythroid differentiation of mouse (29) and human (30) erythroleukemia cells; formation of erythroid colonies in normal mouse bone marrow cultures (31); differentiation of 3T3 fibroblasts into adipocytes (32) ; and stimulation of cell growth of cultured fibroblasts (33, 34). Thus the pharmacological dosage ofheme required to counteract the toxic effect oflead on myelin formation in cultured ganglion cells is consistent with the amounts of this compound required to elicit a wide variety of biochemical, developmental, and morphological changes in other cellular systems.
